The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs

Nature 2026

View at publisher
Authors: Bianca Nogrady
DOI: 10.1038/d41586-026-00228-1
Cited by: 0
References: 9

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Bariatric Surgery and Outcomes

Publication details

Journal / source
Nature
Publication date
12 February 2026
Language
EN